ATE415402T1 - Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen - Google Patents

Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen

Info

Publication number
ATE415402T1
ATE415402T1 AT03771620T AT03771620T ATE415402T1 AT E415402 T1 ATE415402 T1 AT E415402T1 AT 03771620 T AT03771620 T AT 03771620T AT 03771620 T AT03771620 T AT 03771620T AT E415402 T1 ATE415402 T1 AT E415402T1
Authority
AT
Austria
Prior art keywords
made therefrom
spengler reaction
compounds made
modified pictet
pictet
Prior art date
Application number
AT03771620T
Other languages
English (en)
Inventor
Mark Orme
Michael Martinelli
Christopher Doecke
Joseph Pawlak
Erik Chelius
Original Assignee
Lilly Icos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31191375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE415402(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc
Application granted granted Critical
Publication of ATE415402T1 publication Critical patent/ATE415402T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Confectionery (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
AT03771620T 2002-07-31 2003-07-14 Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen ATE415402T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40038602P 2002-07-31 2002-07-31
US46016103P 2003-04-03 2003-04-03

Publications (1)

Publication Number Publication Date
ATE415402T1 true ATE415402T1 (de) 2008-12-15

Family

ID=31191375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03771620T ATE415402T1 (de) 2002-07-31 2003-07-14 Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen

Country Status (19)

Country Link
US (2) US7550479B2 (de)
EP (1) EP1546149B1 (de)
JP (2) JP2005536567A (de)
KR (1) KR100937915B1 (de)
CN (1) CN100430395C (de)
AT (1) ATE415402T1 (de)
AU (1) AU2003256539B2 (de)
BR (1) BR0313070B1 (de)
CA (1) CA2492540C (de)
DE (1) DE60324949D1 (de)
EA (1) EA008666B1 (de)
EG (1) EG23843A (de)
ES (1) ES2318175T3 (de)
IL (2) IL166255A (de)
MX (1) MXPA05001139A (de)
NO (1) NO331775B1 (de)
NZ (1) NZ537784A (de)
PL (1) PL216529B1 (de)
WO (1) WO2004011463A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005116030A1 (en) * 2004-05-31 2005-12-08 Matrix Laboratories Ltd A process for the preparation of tadalafil
EP2216329A1 (de) * 2004-10-28 2010-08-11 Dr. Reddy's Laboratories Ltd. Verfahren zur Herstellung von Tadalafil
US20060111571A1 (en) * 2004-11-02 2006-05-25 Shlomit Wizel Tadalafil crystal forms and processes for preparing them
WO2006091980A1 (en) * 2005-02-25 2006-08-31 Teva Pharmaceutical Industries Ltd. Process of purifying tadalafil
CA2599378A1 (en) * 2005-02-25 2006-08-31 Teva Pharmaceutical Industries Ltd. Tadalafil having a large particle size and a process for preparation thereof
CA2596667A1 (en) * 2005-02-25 2006-08-31 Teva Pharmaceutical Industries Ltd. Process of synthesizing tadalafil
ES2278552T1 (es) * 2005-04-12 2007-08-16 Teva Pharmaceutical Industries Ltd Preparacion de intermediarios de tadalafil.
WO2007052283A1 (en) * 2005-10-31 2007-05-10 Alembic Limited An improved process for preparing tadalafil and its intermediate
EP2004644A1 (de) * 2006-03-24 2008-12-24 Glenmark Pharmaceuticals Limited Verfahren zur herstellung von tadalafil
KR101035742B1 (ko) * 2006-09-28 2011-05-20 신에쓰 가가꾸 고교 가부시끼가이샤 신규 광산 발생제 및 이것을 이용한 레지스트 재료 및 패턴형성 방법
WO2008100886A1 (en) * 2007-02-12 2008-08-21 Auspex Pharmaceuticals, Inc. Preparation and use of deuterated udenafil analogues as highly selective pde5 modulators for the treatment of erectile dysfunction
PT2170880E (pt) 2007-06-29 2012-10-29 Ranbaxy Lab Ltd Processo para a preparação de intermediários de compostos tetracíclicos
ITMI20080285A1 (it) * 2008-02-22 2009-08-23 Endura Spa Procedimento per la preparazione di esteri di acidi tetraidro-1h-betacarbolin-3-carbossilici
EP2107059A1 (de) 2008-03-31 2009-10-07 LEK Pharmaceuticals D.D. Umwandlung von Tryptophan in ß-Carbolinderivate
PL385356A1 (pl) 2008-06-03 2009-12-07 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania tadalafilu
CN101906103A (zh) * 2010-08-08 2010-12-08 浙江华海药业股份有限公司 四氢-β-咔啉化合物合成方法的改进
ES2541421T3 (es) * 2011-02-10 2015-07-20 Interquim, S.A. Procedimiento de obtención de compuestos derivados de tetrahidro-ß-carbolina
CN102367253B (zh) * 2011-09-20 2016-04-06 浙江华海药业股份有限公司 一种制备他达拉非晶型a的方法
AR099416A1 (es) 2014-02-28 2016-07-20 Lilly Co Eli Terapia combinada para la hipertensión resistente
CN103980275B (zh) * 2014-05-14 2016-09-28 湖北省医药工业研究院有限公司 磷酸二酯酶5抑制剂他达拉非的制备方法
CN104151313B (zh) * 2014-07-13 2019-04-09 浙江华海药业股份有限公司 一种纯化他达拉非中间体的方法
EP3466951B1 (de) 2014-07-23 2022-01-19 KRKA, d.d., Novo mesto Verfahren zur herstellung des cgmp-phosphodiesterasehemmers und orale pharmazeutische formulierung mit tadalafil-co-präzipitaten
CN105842350B (zh) * 2015-05-14 2018-11-13 湖北生物医药产业技术研究院有限公司 利用高效液相色谱分析他达拉非合成中间体的方法
CN105061428B (zh) * 2015-08-26 2019-12-27 浙江华海药业股份有限公司 一种精制他达拉非的方法
CN106674223A (zh) * 2016-06-29 2017-05-17 浙江华海药业股份有限公司 一种精制他达拉非的方法
CN107663210A (zh) * 2016-07-28 2018-02-06 常州爱诺新睿医药技术有限公司 一种新的制备无水他达拉非晶型i的方法
CN106279155B (zh) * 2016-08-02 2019-03-19 扬子江药业集团四川海蓉药业有限公司 他达拉非的杂质对照品及其制备方法
CN109053724A (zh) * 2018-08-22 2018-12-21 上海青平药业有限公司 一种制备他达拉非过程中的杂质及该杂质的制备方法和他达拉非的纯化方法以及用途
CN110437228B (zh) * 2019-07-22 2022-06-14 山东省药学科学院 一种他达拉非及其中间体的制备方法
US10947253B2 (en) 2019-08-05 2021-03-16 Ankh Life Sciences Limited Fused polycyclic dimers
CN110790764B (zh) * 2019-11-27 2021-04-06 四川省通园制药集团有限公司 一种一锅法制备他达拉非的方法
US12129265B2 (en) 2020-07-21 2024-10-29 Ankh Life Sciences Limited Therapeutic agents and uses thereof
CN114057738A (zh) * 2021-12-14 2022-02-18 京博农化科技有限公司 一种氯吲哚酰肼的合成方法
CN114805345B (zh) * 2022-04-27 2023-11-10 山东省药学科学院 一种他达拉非中间体顺式四氢咔啉盐酸盐的制备方法
CN116715667A (zh) * 2023-06-20 2023-09-08 常州制药厂有限公司 一种他达拉非新晶型b及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401090D0 (en) * 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
GB9514465D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
EP1332144B1 (de) * 2000-11-06 2006-08-23 Lilly Icos LLC Indolderivate als pde5-inhibitoren
WO2002098877A1 (en) * 2001-06-05 2002-12-12 Lilly Icos Llc Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives

Also Published As

Publication number Publication date
ES2318175T3 (es) 2009-05-01
BR0313070B1 (pt) 2014-09-09
IL200692A0 (en) 2010-05-17
AU2003256539B2 (en) 2010-03-04
EP1546149B1 (de) 2008-11-26
KR100937915B1 (ko) 2010-01-21
EG23843A (en) 2007-10-17
IL200692A (en) 2011-11-30
MXPA05001139A (es) 2005-05-16
NZ537784A (en) 2008-01-31
US7550479B2 (en) 2009-06-23
JP2009235096A (ja) 2009-10-15
US20090312548A1 (en) 2009-12-17
JP4994427B2 (ja) 2012-08-08
IL166255A (en) 2010-04-29
EP1546149A1 (de) 2005-06-29
CN100430395C (zh) 2008-11-05
KR20050030961A (ko) 2005-03-31
PL375092A1 (en) 2005-11-14
WO2004011463A1 (en) 2004-02-05
CA2492540C (en) 2010-05-04
PL216529B1 (pl) 2014-04-30
NO20051022L (no) 2005-04-22
JP2005536567A (ja) 2005-12-02
EA008666B1 (ru) 2007-06-29
BR0313070A (pt) 2005-06-28
AU2003256539A1 (en) 2004-02-16
CN1671706A (zh) 2005-09-21
EA200500264A1 (ru) 2005-08-25
CA2492540A1 (en) 2004-02-05
NO331775B1 (no) 2012-03-26
US20060004203A1 (en) 2006-01-05
DE60324949D1 (de) 2009-01-08
IL166255A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
DE60324949D1 (de) Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen
MXPA04000449A (es) Procedimiento para preparacion de derivados de amidina.
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
WO2003014336A1 (en) Process for preparing hematopoietic stem cells
EA200802088A1 (ru) Способы обработки скважины
NO20062092L (no) Nye fremgangsmater for fremstilling av N-desmetylzopiklon og optisk rent (+)-N-desmetylzopiklon og optisk rent (-)-N-desmetylzopiklon
GEP20074230B (en) Phosphate prodrugs of fluorooxindoles
TW200700725A (en) Detection of nucleic acid associated with disease
NO20050929L (no) Fremgangsmater for fremstilling, isolering og rensing av epotilon B og rontgen krystallstrukturer av eptilon B
EP1457487A4 (de) Verfahren zur herstellung optisch aktiver cis-piperidinderivate
TW200500483A (en) Working-parts with AlCr-containing hard-material layer and its production method
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
PL1561811T3 (pl) Sposób wytwarzania L-treoniny przy użyciu mikroorganizmu posiadającego inaktywowany gen GalR
SE0200843D0 (sv) Chemical compounds
AU2002244906A1 (en) Formation of neolignan by ddq mediated dimerisation of dihydroasarone
AU2003261327A8 (en) Base assemblies, methods of production and uses thereof
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA04004526A (es) N-metil-homocisteinas, su uso y metodo para su produccion.
ITMI20041872A1 (it) Processo per la preparazione di citalopram e di scitalopram
DE50109809D1 (de) Verfahren zur Herstellung von D- oder L-Menthol
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
ATE537160T1 (de) Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat
ATE374207T1 (de) Verfahren zur herstellung von lipid ii
PL367981A1 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
NO20052329L (no) Fremgangsmate for rensingen av 1,4-butandiol-mononitrat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties